PRQR
ProQR Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.92 / 10
Netural
With a fund flow rating of 7.52/10, the stock shows robust fund flow characteristics. Supportive momentum from no significant trends trends is partially offset by concerning overall, block, Small, Medium, Large, and Extra-large patterns, pointing to positive capital flow trajectory. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(100.0%) from 1 analytical reports, supported by 2.31 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-04
InstitutionChardan Capital
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of PRQR?
- PRQR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.92/10 (Netural).
